6533b831fe1ef96bd129863f
RESEARCH PRODUCT
The effect of cannabinoid receptor agonist WIN 55,212-2 on anxiety-like behavior and locomotion in a genetic model of absence seizures in the elevated plus-maze.
Daniel CassarManuela RadicMaurizio CasarrubeaVincenzo CrunelliGiuseppe Di Giovannisubject
PharmacologyCannabinoid Receptor AgonistsModels GeneticMorpholinesNECWIN 55212-2 2AnxietyNaphthalenesSettore BIO/09 - FisiologiaBenzoxazinesRatsElevated Plus Maze TestPsychiatry and Mental healthEpilepsy AbsenceSeizuresPhysiology (medical)GAERSAnimalsPharmacology (medical)Elevated Plus-MazeRats WistarLocomotiondescription
GAERS and NEC rats were treated with cannabinoid 1/2 receptor agonist WIN 55,212-2 2 mg/kg and tested on the Elevated Plus-Maze
year | journal | country | edition | language |
---|---|---|---|---|
2022-04-26 | CNS neurosciencetherapeutics |